Al-Meghaiseeb Ebtissam Saleh, Al-Otaibi Mulfi Mubarak, Al-Robayan Abdulrahman, Al-Amro Reem, Al-Malki Ahmd Saad, Arfin Misbahul, Al-Asmari Abdulrahman K
Ebtissam Saleh Al-Meghaiseeb, Mulfi Mubarak Al-Otaibi, Abdulrahman Al-Robayan, Reem Al-Amro, Ahmd Saad Al-Malki, Department of Gastroenterology, Prince Sultan Military Medical City, Riyadh 11159, Saudi Arabia.
World J Gastroenterol. 2015 Jan 21;21(3):897-904. doi: 10.3748/wjg.v21.i3.897.
To study the association of apolipoprotein E (APOE) polymorphisms with the susceptibility of inflammatory bowel disease (IBD) in Saudi patients.
APOE genotyping was performed to evaluate the allele and genotype frequencies in 378 Saudi subjects including IBD patients with ulcerative colitis (n = 84) or Crohn's disease (n = 94) and matched controls (n = 200) using polymerase chain reaction and reverse-hybridization techniques.
The frequencies of the APOE ε2 allele and ε2/ε3 and ε2/ε4 genotypes were significantly higher in IBD patients than in controls (P < 0.05), suggesting that the ε2 allele and its heterozygous genotypes may increase the susceptibility to IBD. On the contrary, the frequencies of the ε3 allele and ε3/ε3 genotype were lower in IBD patients as compared to controls, suggesting a protective effect of APOE ε3 for IBD. The prevalence of the ε4 allele was also higher in the patient group compared to controls, suggesting that the ε4 allele may also increase the risk of IBD. Our results also indicated that the APOE ε4 allele was associated with an early age of IBD onset. No effect of gender or type of IBD (familial or sporadic) on the frequency distribution of APOE alleles and genotypes was noticed in this study.
APOE polymorphism is associated with risk of developing IBD and early age of onset in Saudi patients, though further studies with a large-size population are warranted.
研究沙特患者中载脂蛋白E(APOE)基因多态性与炎症性肠病(IBD)易感性的关联。
采用聚合酶链反应和反向杂交技术,对378名沙特受试者(包括84例溃疡性结肠炎IBD患者、94例克罗恩病IBD患者和200例匹配对照)进行APOE基因分型,以评估等位基因和基因型频率。
IBD患者中APOE ε2等位基因以及ε2/ε3和ε2/ε4基因型的频率显著高于对照组(P < 0.05),这表明ε2等位基因及其杂合基因型可能增加IBD的易感性。相反,与对照组相比,IBD患者中ε3等位基因和ε3/ε3基因型的频率较低,提示APOE ε3对IBD有保护作用。患者组中ε4等位基因的患病率也高于对照组,表明ε4等位基因也可能增加IBD的风险。我们的结果还表明,APOE ε4等位基因与IBD发病年龄较早有关。本研究未发现性别或IBD类型(家族性或散发性)对APOE等位基因和基因型频率分布有影响。
APOE基因多态性与沙特患者发生IBD的风险及发病年龄较早有关,不过仍需对大量人群进行进一步研究。